Bruce Lisanti is the president and chief executive officer of Monarch, bringing more than three decades of experience as a senior level executive in healthcare, technology and services. With extensive experience in strategic planning, operations, business development and finance, Bruce is leading the Monarch team in providing the safest technology platform for insulin dosing.
Prior to his tenure as CEO at Monarch, Bruce served as the principal in several successful high-growth technology companies, leading companies from the early stages to over $500 million in revenue. He has also led the identification, financing and integration of more than 40 acquisitions. Bruce began his career at General Electric Company (GE), where he helped a new division excel from startup to over $1.2B in revenue.